title: Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
authors.forename: W E
authors.initials: WE
authors.lastname: Aulitzky
authors.forename: H
authors.initials: H
authors.lastname: Tilg
authors.forename: D
authors.initials: D
authors.lastname: Niederwieser
authors.forename: M
authors.initials: M
authors.lastname: Hackl
authors.forename: B
authors.initials: B
authors.lastname: Meister
authors.forename: C
authors.initials: C
authors.lastname: Huber
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D015774:Ganciclovir; D006801:Humans; D007116:Immunization, Passive; D011024:Pneumonia, Viral / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D011183:Postoperative Complications / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir